Search research articles
Contact Us
Filters
Showing results (41-50 of 89) with videos related to
Page
of 9
Sort By:
Journal of Cellular and Molecular Medicine
|
July 7, 2026
circFOXP1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Regulating EREG/MAPK/ERK Axis
Leyi Huang, Dan Su, Rihua He, et al.
Cell Biology International
|
July 22, 2014
Flagellin modulates TIM4 expression in mast cells
Linjing Li, Lihua Mo, Huijie Hao, et al.
Cell Death & Disease
|
April 20, 2018
Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma
Huilin Ye, Quanbo Zhou, Shangyou Zheng, et al.
Therapeutic Advances in Medical Oncology
|
July 24, 2020
Prognostic and clinicopathological significance of systemic immune-inflammation index in colorectal cancer: a meta-analysis
Meilian Dong, Yonggang Shi, Jing Yang, et al.
Journal of Translational Medicine
|
May 1, 2015
High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma
Yibiao Ye, Jie Chen, Yu Zhou, et al.
FEBS Letters
|
July 24, 2012
Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3
Bing Zeng, Zhihua Li, Rufu Chen, et al.
Journal of Cancer
|
June 7, 2021
LINC01272/miR-876/ITGB2 axis facilitates the metastasis of colorectal cancer via epithelial-mesenchymal transition
Zhenqiang Sun, Qin Dang, Zaoqu Liu, et al.
Frontiers in Cell and Developmental Biology
|
November 1, 2021
Effects of Tumor-Derived Exosome Programmed Death Ligand 1 on Tumor Immunity and Clinical Applications
Bo Shao, Qin Dang, Zhuang Chen, et al.
Oncology Letters
|
July 17, 2018
Anticancer effect of HOTTIP regulates human pancreatic cancer via the metabotropic glutamate receptor 1 pathway
Yibiao Ye, Yanshan Li, Yunping Wei, et al.
International Journal of Cancer
|
April 9, 2013
Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism
Yu Zhou, Quanbo Zhou, Qing Lin, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 89) with videos related to
Sort By:
Page
of 9
Journal of Cellular and Molecular Medicine
|
July 7, 2026
circFOXP1 Promotes Pancreatic Ductal Adenocarcinoma Progression Through Regulating EREG/MAPK/ERK Axis
Leyi Huang, Dan Su, Rihua He, et al.
Cell Biology International
|
July 22, 2014
Flagellin modulates TIM4 expression in mast cells
Linjing Li, Lihua Mo, Huijie Hao, et al.
Cell Death & Disease
|
April 20, 2018
Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma
Huilin Ye, Quanbo Zhou, Shangyou Zheng, et al.
Therapeutic Advances in Medical Oncology
|
July 24, 2020
Prognostic and clinicopathological significance of systemic immune-inflammation index in colorectal cancer: a meta-analysis
Meilian Dong, Yonggang Shi, Jing Yang, et al.
Journal of Translational Medicine
|
May 1, 2015
High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma
Yibiao Ye, Jie Chen, Yu Zhou, et al.
FEBS Letters
|
July 24, 2012
Epigenetic regulation of miR-124 by hepatitis C virus core protein promotes migration and invasion of intrahepatic cholangiocarcinoma cells by targeting SMYD3
Bing Zeng, Zhihua Li, Rufu Chen, et al.
Journal of Cancer
|
June 7, 2021
LINC01272/miR-876/ITGB2 axis facilitates the metastasis of colorectal cancer via epithelial-mesenchymal transition
Zhenqiang Sun, Qin Dang, Zaoqu Liu, et al.
Frontiers in Cell and Developmental Biology
|
November 1, 2021
Effects of Tumor-Derived Exosome Programmed Death Ligand 1 on Tumor Immunity and Clinical Applications
Bo Shao, Qin Dang, Zhuang Chen, et al.
Oncology Letters
|
July 17, 2018
Anticancer effect of HOTTIP regulates human pancreatic cancer via the metabotropic glutamate receptor 1 pathway
Yibiao Ye, Yanshan Li, Yunping Wei, et al.
International Journal of Cancer
|
April 9, 2013
Evaluation of risk factors for extrahepatic cholangiocarcinoma: ABO blood group, hepatitis B virus and their synergism
Yu Zhou, Quanbo Zhou, Qing Lin, et al.
Page
of 9